VMD - Viemed Healthcare, Inc.
Viemed Healthcare NASDAQ: VMD outlined its growth strategy, product diversification and capital allocation priorities at the Midwest IDEAS Conference, emphasizing its focus on providing in-home care for patients with complex respiratory conditions.
Viemed Healthcare, Inc. (VMD) Q2 2026 Earnings Call Transcript
Viemed Healthcare NASDAQ: VMD reported record second-quarter revenue as growth in its ventilator business resumed under the updated Medicare coverage framework and newer service lines expanded.
Viemed Healthcare, Inc. (VMD) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.08 per share a year ago.
LAFAYETTE, LA / ACCESS Newswire / August 3, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it has reported its financial results for the three and six months ended June 30, 2026, and updated guidance for the full year ending December 31, 2026. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended June 30, 2026 were $78.1 million, setting a Company record, representing an increase of $15.0 million, or 23.9%, compared with the prior-year quarter and an increase of approximately 3.6% sequentially.
LAFAYETTE, LA / ACCESS Newswire / July 21, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that it will host its Second Quarter 2026 Earnings Conference Call on Tuesday, August 4, 2026, at 11:00 a.m. EDT. Interested parties may participate in the call by dialing: 877-407-6176 (US Toll-Free) +1 201-689-8451 (International) Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=peVp8cbE Following the live call, a replay will be available in the Investor Relations section of the Company's website at www.viemed.com.
Surgery Partners operates a massive nationwide network of outpatient surgical facilities and hospitals. Viemed Healthcare is a high-growth specialist focusing on home-based respiratory care and disease management.
Dallas, Texas--(Newsfile Corp. - May 12, 2026) - Viemed Healthcare, Inc. (NASDAQ: VMD). Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (NASDAQ: VMD).
Viemed Healthcare, Inc. (VMD) Q1 2026 Earnings Call Transcript
Viemed Healthcare, Inc. (VMD) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.06 per share a year ago.
LAFAYETTE, LA / ACCESS Newswire / May 5, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it has reported its financial results for the three months ended March 31, 2026, and updated guidance for the full year ending December 31, 2026. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended March 31, 2026 were $75.4 million, representing an increase of $16.3 million, or 28%, over net revenues reported for the comparable quarter ended March 31, 2025.
LAFAYETTE, LA / ACCESS Newswire / April 21, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that it will host its First Quarter 2026 Earnings Conference Call on Wednesday, May 6, 2026, at 11:00 a.m. EDT. Interested parties may participate in the call by dialing: 877-407-6176 (US Toll-Free) +1 201-689-8451 (International) Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=MWjE55eM Following the live call, a replay will be available in the Investor Relations section of the Company's website at www.viemed.com.
Viemed Healthcare, Inc. (NASDAQ: VMD - Get Free Report) President Michael Moore sold 31,570 shares of the firm's stock in a transaction on Wednesday, March 18th. The stock was sold at an average price of $9.42, for a total value of $297,389.40. Following the completion of the sale, the president directly owned 1,691,044 shares of the
LAFAYETTE, LA / ACCESS Newswire / March 16, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced it will present and host one-on-one meetings with investors at Sidoti's Small-Cap Virtual Investor Conference, taking place on March 18-19, 2026. The presentation will begin at 1:45 p.m.
Dallas, Texas--(Newsfile Corp. - March 11, 2026) - Viemed Healthcare, Inc. (NASDAQ: VMD). Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (NASDAQ: VMD).
Viemed Healthcare, Inc. (VMD) Q4 2025 Earnings Call Transcript
LAFAYETTE, LA / ACCESS Newswire / March 4, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that its Board of Directors has authorized a share repurchase program effective through March 2027. Under the share repurchase program, which constitutes a normal course issuer bid under applicable Canadian securities laws, Viemed may purchase up to 1,930,131 common shares of the Company ("the Common Shares") from time to time in accordance with applicable securities laws, representing approximately 5% of the total issued and outstanding Common Shares as of March 4, 2026.
LAFAYETTE, LA / ACCESS Newswire / March 4, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it has reported its financial results for the three months and year ended December 31, 2025, and issued its guidance for the full year ending December 31, 2026. Fourth Quarter and Full Year Operational Highlights (all dollar amounts are USD): Net revenues for the quarter ended December 31, 2025 were a company record $76.2 million, an increase of $15.5 million, or 26%, over net revenues reported for the comparable quarter ended December 31, 2024.
LAFAYETTE, LA / ACCESS Newswire / February 24, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that it will host its Year End 2025 earnings conference call on Thursday, March 5, 2026, at 11:00 a.m. ET. Interested parties may participate in the call by dialing: 877-407-6176 (US Toll-Free) +1 201-689-8451 (International) Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=hp8iUwVS Following the live call, a replay will be available in the Investor Relations section of the Company's website at www.viemed.com.
Viemed Healthcare is reiterated as a 'Buy' due to robust revenue, earnings, and cash flow growth, alongside an expanding patient base. Q1 and Q2 2025 saw strong organic growth, with Lehan's acquisition quickly accretive and driving further patient count gains. Despite recently trimming FY2025 top-line guidance, VMD's valuation remains compelling with P/E, P/S, and P/B well below 5-year averages.